|Bid||182.66 x 1000|
|Ask||182.73 x 800|
|Day's Range||180.17 - 187.13|
|52 Week Range||180.17 - 236.62|
|Beta (3Y Monthly)||-0.01|
|PE Ratio (TTM)||10.96|
|Earnings Date||Jan 9, 2019|
|Forward Dividend & Yield||2.96 (1.55%)|
|1y Target Est||245.82|
New Age Beverages (NBEV) stock has been on the run for the last few days. On December 12, the stock rose 10.5%. At 9:46 AM EST on December 13, the stock was trading with 4.5% gains. New Age Beverages stock has increased for the fourth consecutive day. So far this week, New Age Beverages has increased 28.1%. Earlier in December, the company announced its merger with Morinda Holdings. We’ll discuss what has been helping New Age Beverages stock make big moves this week.
In the U.S., marijuana is still federally illegal. For investors, the key question is how to profit from hemp becoming legal. When I wrote “How to potentially become a marijuana millionaire, albeit carefully,” the most important word in the headline was “carefully.” Being careful also applies to hemp.
Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
NEW YORK, NY / ACCESSWIRE / December 12, 2018 / Both Constellation Brands and Canopy Growth were gaining positive remarks this week sending shares higher. The Market Edge Initiates Coverage on: Canopy ...
Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
Despite their well-publicized fall from grace, several marijuana stocks have stabilized from their severe correction. Whether it’s political unrest in the Middle East, the spiraling protests in Paris or the ugly Huawei controversy, marijuana for now is mostly a North American issue. Second, medical cannabis potentially offers significant social utility.
Altria Group (NYSE:MO) is joining the mega-cap firms eager to hedge against a potential decline in their home business. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group (NASDAQ:CRON). Meanwhile, Constellation Brands (NYSE:STZ) bought Canopy Growth (NYSE:CGC) at the beginning of this year.
Costco (COST) continues to be one of the dominant retail wholesalers based on the breadth and quality of merchandise offered.
Ponying up $1.8 billion for a 45% stake in Cronos could come back to haunt the maker of Marlboro cigarettes.
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.
Constellation Brands (STZ) is a favored stock, owing to its robust surprise trend, strength in the beer business and solid business growth plans, including investment in Canopy Growth.
If there was one investment that took the financial markets by storm in 2018, it was marijuana stocks. The group, headlined by Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), Aurora (NYSE:ACB), and Cronos (NASDAQ:CRON), wasn’t well known to investors at the beginning of the year. First, everyone started getting excited in 2018 about the nationwide legalization of cannabis in Canada in October.
Since Constellation first announced its $4 billion investment in Canopy Growth, shares have fallen almost 15 percent, a good entry point, Azer says. The cannabis investment is "a strategic long-term investment that should pay dividends as the Canadian adult use market sorts itself out," she added.
Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of September 30. The results of that effort will be put on display in this […]
Earlier this week, Cronos (NASDAQ:CRON) put out a press release confirming that tobacco company Altria Group (NYSE:MO) was considering an investment in the company, but that no decision was finalized. Altria announced a massive move into the tobacco space. It decided to make a C$2.4 billion ($1.8 billion) strategic investment into Cronos, confirming the earlier rumors.